522 related articles for article (PubMed ID: 20469967)
21. RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease.
Bourreille A; Doubremelle M; de la Blétière DR; Segain JP; Toquet C; Buelow R; Galmiche JP
Scand J Gastroenterol; 2003 May; 38(5):526-32. PubMed ID: 12795464
[TBL] [Abstract][Full Text] [Related]
22. Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling.
An MM; Fan KX; Zhang JD; Li HJ; Song SC; Liu BG; Gao PH; Zhou Q; Jiang YY
Pharmacol Res; 2005 Sep; 52(3):234-44. PubMed ID: 15925518
[TBL] [Abstract][Full Text] [Related]
23. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
Elinav E; Waks T; Eshhar Z
Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cells treated by Trichinella spiralis muscle larval excretory/secretory products alleviate TNBS-induced colitis in mice.
Jin X; Yang Y; Bai X; Shi H; Zhang W; Zhang Z; Jia W; Lin J; Liu M; Liu X
Int Immunopharmacol; 2019 May; 70():378-386. PubMed ID: 30852293
[TBL] [Abstract][Full Text] [Related]
25. Total glucosides of peony attenuates 2,4,6-trinitrobenzene sulfonic acid/ethanol-induced colitis in rats through adjustment of TH1/TH2 cytokines polarization.
Zhang Y; Zhou R; Zhou F; Cheng H; Xia B
Cell Biochem Biophys; 2014 Jan; 68(1):83-95. PubMed ID: 23771723
[TBL] [Abstract][Full Text] [Related]
26. Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells.
Sasaoka T; Ito M; Yamashita J; Nakajima K; Tanaka I; Narita M; Hara Y; Hada K; Takahashi M; Ohno Y; Matsuo T; Kaneshiro Y; Tanaka H; Kaneko K
Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G568-76. PubMed ID: 21193526
[TBL] [Abstract][Full Text] [Related]
27. A new model of chronic hapten-induced colitis in young rats.
Fitzpatrick LR; Meirelles K; Small JS; Puleo FJ; Koltun WA; Cooney RN
J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):240-50. PubMed ID: 20118800
[TBL] [Abstract][Full Text] [Related]
28. 1,3-Diphenylpropenone ameliorates TNBS-induced rat colitis through suppression of NF-κB activation and IL-8 induction.
Park SY; Ku SK; Lee ES; Kim JA
Chem Biol Interact; 2012 Mar; 196(1-2):39-49. PubMed ID: 22410118
[TBL] [Abstract][Full Text] [Related]
29. Melatonin reduces the expression of chemokines in rat with trinitrobenzene sulfonic acid-induced colitis.
Li JH; Zhou W; Liu K; Li HX; Wang L
Saudi Med J; 2008 Aug; 29(8):1088-94. PubMed ID: 18690297
[TBL] [Abstract][Full Text] [Related]
30. Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis.
Mencarelli A; Distrutti E; Renga B; Cipriani S; Palladino G; Booth C; Tudor G; Guse JH; Hahn U; Burnet M; Fiorucci S
Eur J Pharmacol; 2011 Aug; 665(1-3):29-39. PubMed ID: 21554873
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
Gonzalez-Rey E; Delgado M
Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic effects of triptolide on interleukin-10 gene-deficient mice with colitis.
Wei X; Gong J; Zhu J; Niu L; Zhu W; Li N; Li J
Int Immunopharmacol; 2008 Dec; 8(13-14):1808-12. PubMed ID: 18804190
[TBL] [Abstract][Full Text] [Related]
33. Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis.
Bhatia M; Landolfi C; Basta F; Bovi G; Ramnath RD; de Joannon AC; Guglielmotti A
Inflamm Res; 2008 Oct; 57(10):464-71. PubMed ID: 18827968
[TBL] [Abstract][Full Text] [Related]
34. Blocking TNF-α by combination of TNF-α- and TNFR-binding cyclic peptide ameliorates the severity of TNBS-induced colitis in rats.
Yin B; Hu X; Wang J; Liang H; Li X; Niu N; Li B; Jiang X; Li Z
Eur J Pharmacol; 2011 Apr; 656(1-3):119-24. PubMed ID: 21296062
[TBL] [Abstract][Full Text] [Related]
35. Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis.
Isozaki Y; Yoshida N; Kuroda M; Handa O; Takagi T; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
Scand J Gastroenterol; 2006 Aug; 41(8):944-53. PubMed ID: 16803693
[TBL] [Abstract][Full Text] [Related]
36. IL-10 gene therapy prevents TNBS-induced colitis.
Lindsay J; Van Montfrans C; Brennan F; Van Deventer S; Drillenburg P; Hodgson H; Te Velde A; Sol Rodriguez Pena M
Gene Ther; 2002 Dec; 9(24):1715-21. PubMed ID: 12457286
[TBL] [Abstract][Full Text] [Related]
37. The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice.
Daniel C; Radeke HH; Sartory NA; Zahn N; Zuegel U; Steinmeyer A; Stein J
J Pharmacol Exp Ther; 2006 Nov; 319(2):622-31. PubMed ID: 16914561
[TBL] [Abstract][Full Text] [Related]
38. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
39. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
40. [Modulation of intestinal mucosal inflammatory factors by curcumin in rats with colitis].
Jian YT; Wang JD; Mai GF; Zhang YL; Lai ZS
Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1353-8. PubMed ID: 15604057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]